⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

GOSS

Gossamer Bio, Inc.

Healthcare · Biotechnology

9.605USD

+0.1450 (+1.53%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on GOSS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 9.61
P/E—
Dvd Ind Yld0.0%
P/B—
P/S1.1
Curr EV/T12M EBITDA-0.3
Mkt Cap (USD)0.1B
Curr EV (USD)0.0B
2)

Per Share Data

EPS T12M-0.70
DPS—
Bk Val Per Sh-0.19
Rev/Sh0.16
Cash/Sh9.33
Curr Shares Out6.1M
FCF/Sh-0.49
3)

Cash Flow Analysis

P/CF-0.4
Curr P/FCF-0.4
CF/NI1.3
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-305.2%
Eff Interest Rate176.4%
4)

Growth Potential

Dil EPS 1Y Gr-200.0%
Cap 1Y Gr-516.2%
BPS 1Y Gr-512.1%
R&D To Sales—
Retention Rate—
Rev 1Y Gr-57.7%
FCF 1Y Gr-4840.7%
Assets 1Y Gr-45.4%
5)

Profitability

EBITDA-0.2B
EBIT-0.2B
Operating Margin-311.7%
Pretax Margin-317.6%
Net Margin-235.0%
ROA-78.8%
ROE178.7%
ROC174.0%
Asset Turnover0.34
6)

Structure

Current Ratio0.53
Quick Ratio0.46
Debt/Assets0.0%
Debt/Com Eq0.0%
Net Debt/EBITDA0.25
Tot Debt/Capital0.0%
Gross Margin100.0%
EBIT/Int Exp-15.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.